# Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees:  Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/submitting-separate-marketing-applications-and-clinical-data-for-purposes-of-assessing-user-fees-guidance-for-industry/2c9aed18-87e7-4700-8c3b-593f58e268e8

> FDA guidance document: Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees:  Guidance for Industry. Issue date: January 03, 2005. Get complete insights and analysis.

---

## Details

- Title: Submitting Separate Marketing Applications and Clinical Data for Purposes of Assessing User Fees:  Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2005-01-03
- Last Changed: 2020-05-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2001-D-0134">FDA-2001-D-0134</a>

## Related Documents

- [Exposure-Response Relationships — Study Design, Data Analysis, and Regulatory Applications](https://www.globalkeysolutions.net/guidances/guidance-document/exposure-response-relationships-study-design-data-analysis-and-regulatory-applications/e3b78410-ce8b-46f8-9ae8-b9df1485d11e)
- [Q1E Evaluation of Stability Data](https://www.globalkeysolutions.net/guidances/guidance-document/q1e-evaluation-of-stability-data/e4413f7a-4a88-4baf-b13c-f5314f2b7f64)
- [E9 Statistical Principles for Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e9-statistical-principles-for-clinical-trials/d427b5ed-dd16-417e-adc2-9f35d3a3df23)